WLWanguo Liu

Wanguo Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wanguo Liu has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Rui Gu

    Department of Orthopaedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China

    12 shared publications
  • Chunyu Xiang

    Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, P. R. China

    9 shared publications
  • Wenqi Luo

    9 shared publications
  • Fengshuo Guo

    Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, P. R. China

    5 shared publications
  • Xiaodong He

    Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, P. R. China

    5 shared publications
  • Renrui Niu

    Department of Orthopedic Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China

    4 shared publications

Latest Publications

  • Open Access

    A zinc-coordinated cascade-responsive therapeutic nanoassembly for remodeling the pathological microenvironment and restoring mitochondrial homeostasis in spinal cord injury

    by Chunyu Xiang, Xiaodong He, Fengshuo Guo, Haowen Luo, Liumin He, Wanguo Liu, Rui Gu

    Secondary injury after spinal cord injury (SCI) is sustained by coupled oxidative stress and inflammation, which drives neuronal apoptosis and bioenergetic failure. Here, a cascade-responsive Zn2+-centered nanoassembly (Zn-PC/PA@Gel) is constructed through stepwise coordination among Zn2+, procyanidin (PC), and polyarginine (PA) to form a core-shell architecture with a Zn2+-procyanidin core (Zn-PC) and a Zn2+-polyarginine shell (Zn-PA). In a reactive oxygen species (ROS) rich injury microenvironment, oxidation of guanidino groups in the polyarginine shell enables in situ nitric oxide (NO) release and weakens Zn2+ coordination, triggering controlled shell disassembly for early modulation of local inflammation and tissue microenvironment. The subsequent release of PC and Zn2+ provides continuous antioxidant protection. Zn2+ further restores mitochondrial quality control by regulating the STAT3-FOXO3a-SOD2 axis, thus enhancing mitochondrial autophagy, enhancing endogenous antioxidant defense, and restoring mitochondrial homeostasis and energy metabolism. In a mouse spinal cord contusion model, Zn-PC/PA@Gel mitigated inflammation and oxidative stress, alleviated the burden of mitochondrial dysfunction, protected neurons, and promoted motor recovery, resulting in a Basso Mouse Scale (BMS) score of 7.0 on day 28. Overall, these results support Zn2+ coordinated cascade therapy nanoassembly, which combines microenvironmental regulation with mitochondrial homeostatic recovery to reduce secondary injury after SCI and promote locomotor improvement.

  • Open Access

    The Design Strategies and Applications of Engineered Nanoparticles for Traumatic Brain Injury

    by Chunyu Xiang, Yuhang Zhu, Xu Gao, Fengshuo Guo, Xiaodong He, Wenqi Luo, Wanguo Liu, Rui Gu

    Traumatic brain injury (TBI) is a serious neurological condition. Because of its complex pathophysiological processes, direct treatment options are extremely limited. A key reason for this is the blood-brain barrier (BBB), which makes it difficult for conventional drug molecules to penetrate and maintain effective concentrations in brain tissue. In recent years, nanoparticles have garnered significant attention due to their unique biological properties, enhanced therapeutic effects, and low toxicity. By modifying the surface of nanoparticles with targeting ligands, their penetration capacity can be significantly enhanced, enabling directed delivery to the core injury area and substantially increasing their accumulation at the site of injury. Furthermore, functionally engineered nanoparticles can respond to specific signals in the TBI microenvironment, such as reactive oxygen species (ROS), enzymes, and pH changes, thereby enabling controlled drug release and significantly improving delivery efficiency. This review systematically summarizes the latest advances in engineered nanoparticles for TBI treatment from three perspectives: rational design, therapeutic strategies, and clinical translation.


  • Open Access

    Generation and clearance of myelin debris after spinal cord injury

    by Chaoyuan Li, Wenqi Luo, Irshad Hussain, Renrui Niu, Xiaodong He, Chunyu Xiang, Fengshuo Guo, Wanguo Liu, Rui Gu

    Traumatic spinal cord injury often leads to the disintegration of nerve cells and axons, resulting in a substantial accumulation of myelin debris that can persist for years. The abnormal buildup of myelin debris at sites of injury greatly impedes nerve regeneration, making the clearance of debris within these microenvironments crucial for effective post-spinal cord injury repair. In this review, we comprehensively outline the mechanisms that promote the clearance of myelin debris and myelin metabolism and summarize their roles in spinal cord injury. First, we describe the composition and characteristics of myelin debris and explain its effects on the injury site. Next, we introduce the phagocytic cells involved in myelin debris clearance, including professional phagocytes (macrophages and microglia) and non-professional phagocytes (astrocytes and microvascular endothelial cells), as well as other cells that are also proposed to participate in phagocytosis. Finally, we focus on the pathways and associated targets that enhance myelin debris clearance by phagocytes and promote lipid metabolism following spinal cord injury. Our analysis indicates that myelin debris phagocytosis is not limited to monocyte-derived macrophages, but also involves microglia, astrocytes, and microvascular endothelial cells. By modulating the expression of genes related to phagocytosis and lipid metabolism, it is possible to modulate lipid metabolism disorders and influence inflammatory phenotypes, ultimately affecting the recovery of motor function following spinal cord injury. Additionally, therapies such as targeted mitochondrial transplantation in phagocytic cells, exosome therapy, and repeated trans-spinal magnetic stimulation can effectively enhance the removal of myelin debris, presenting promising potential for future applications.


  • Open Access

    Natural polymer based drug-loaded hydrogel platform for comprehensive care of acute spinal cord injury

    by Mingyu Zhang, Chunyu Xiang, Xin Zhen, Wenqi Luo, Xiaodong He, Fengshuo Guo, Renrui Niu, Wanguo Liu, Rui Gu


  • Open Access

    Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury

    by Zeping Liu, Chunyu Xiang, Xu Zhao, Toshimi Aizawa, Renrui Niu, Jianhui Zhao, Fengshuo Guo, Yueying Li, Wenqi Luo, Wanguo Liu, et al.

    Spinal cord injury (SCI) is a common clinical condition of the central nervous system that can lead to sensory and motor impairment below the injury level or permanent loss of function in severe cases. Dynamic spatiotemporal neuroinflammation is vital to neurological recovery, which is collectively constituted by the dynamic changes in a series of inflammatory cells, including microglia, neutrophils, and astrocytes, among others. Immunomodulatory nanomaterials can readily improve the therapeutic effects and simultaneously overcome various drawbacks associated with treatment, such as the off-target side effects and loss of bioactivity of immune agents during circulation. In this review, we discuss the role of dynamic spatiotemporal inflammation in secondary injuries after SCI, elaborate on the mechanism of action and effect of existing nanomaterials in treating SCI, and summarize the mechanism(s) whereby they regulate inflammation. Finally, the challenges and prospects associated with using nanotechnology to modulate immunotherapy are discussed to provide new insights for future treatment. Deciphering the intricate spatiotemporal mechanisms of neuroinflammation in SCI requires further in-depth studies. Therefore, SCI continues to represent a formidable challenge. Graphical abstract


  • Open Access

    Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety

    by Mingyu Zhang, Chunyu Xiang, Renrui Niu, Xiaodong He, Wenqi Luo, Wanguo Liu, Rui Gu

    Various nanoparticle-based drug delivery systems for the treatment of neurological disorders have been widely studied. However, their inability to cross the blood–brain barrier hampers the clinical translation of these therapeutic strategies. Liposomes are nanoparticles composed of lipid bilayers, which can effectively encapsulate drugs and improve drug delivery across the blood–brain barrier and into brain tissue through their targeting and permeability. Therefore, they can potentially treat traumatic and nontraumatic central nervous system diseases. In this review, we outlined the common properties and preparation methods of liposomes, including thin-film hydration, reverse-phase evaporation, solvent injection techniques, detergent removal methods, and microfluidics techniques. Afterwards, we comprehensively discussed the current applications of liposomes in central nervous system diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, and brain tumors. Most studies related to liposomes are still in the laboratory stage and have not yet entered clinical trials. Additionally, their application as drug delivery systems in clinical practice faces challenges such as drug stability, targeting efficiency, and safety. Therefore, we proposed development strategies related to liposomes to further promote their development in neurological disease research.


  • Top Cited Papers
    Open Access

    CD44-targeting hyaluronic acid-selenium nanoparticles boost functional recovery following spinal cord injury

    by Wenqi Luo, Yueying Li, Jianhui Zhao, Renrui Niu, Chunyu Xiang, Mingyu Zhang, Chunsheng Xiao, Wanguo Liu, Rui Gu

    Background: Therapeutic strategies based on scavenging reactive oxygen species (ROS) and suppressing inflammatory cascades are effective in improving functional recovery after spinal cord injury (SCI). However, the lack of targeting nanoparticles (NPs) with powerful antioxidant and anti-inflammatory properties hampers the clinical translation of these strategies. Here, CD44-targeting hyaluronic acid-selenium (HA-Se) NPs were designed and prepared for scavenging ROS and suppressing inflammatory responses in the injured spinal cord, enhancing functional recovery. Results: The HA-Se NPs were easily prepared through direct reduction of seleninic acid in the presence of HA. The obtained HA-Se NPs exhibited a remarkable capacity to eliminate free radicals and CD44 receptor-facilitated internalization by astrocytes. Moreover, the HA-Se NPs effectively mitigated the secretion of proinflammatory cytokines (such as IL-1β, TNF-α, and IL-6) by microglia cells (BV2) upon lipopolysaccharide-induced inflammation. In vivo experiments confirmed that HA-Se NPs could effectively accumulate within the lesion site through CD44 targeting. As a result, HA-Se NPs demonstrated superior protection of axons and neurons within the injury site, leading to enhanced functional recovery in a rat model of SCI. Conclusions: These results highlight the potential of CD44-targeting HA-Se NPs for SCI treatment.


  • Open Access

    Nanomaterials as therapeutic agents to modulate astrocyte-mediated inflammation in spinal cord injury

    by Wenqi Luo, Yueying Li, Chunyu Xiang, Toshimi Aizawa, Renrui Niu, Yiming Wang, Jianhui Zhao, Zeping Liu, Chaoyuan Li, Wanguo Liu, et al.


  • Top Cited Papers
    Open Access

    Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair

    by Jincheng Li, Wenqi Luo, Chunsheng Xiao, Jianhui Zhao, Chunyu Xiang, Wanguo Liu, Rui Gu

    Traumatic spinal cord injury (SCI) can cause severe neurological impairments. Clinically available treatments are quite limited, with unsatisfactory remediation effects. Residing endogenous neural stem/progenitor cells (eNSPCs) tend to differentiate towards astrocytes, leaving only a small fraction towards oligodendrocytes and even fewer towards neurons; this has been suggested as one of the reasons for the failure of autonomous neuronal regeneration. Thus, finding ways to recruit and facilitate the differentiation of eNSPCs towards neurons has been considered a promising strategy for the noninvasive and immune-compatible treatment of SCI. The present manuscript first introduces the responses of eNSPCs after exogenous interventions to boost endogenous neurogenesis in various SCI models. Then, we focus on state-of-art manipulation approaches that enhance the intrinsic neurogenesis capacity and reconstruct the hostile microenvironment, mainly consisting of pharmacological treatments, stem cell-derived exosome administration, gene therapy, functional scaffold implantation, inflammation regulation, and inhibitory element delineation. Facing the extremely complex situation of SCI, combined treatments are also highlighted to provide more clues for future relevant investigations.


  • Open Access

    Epigallocatechin-3-gallate selenium nanoparticles for neuroprotection by scavenging reactive oxygen species and reducing inflammation

    by Yiming Wang, Wenqi Luo, Feng Lin, Wanguo Liu, Rui Gu

    Purpose: Spinal cord injury (SCI) is a severely crippling injury. Scavenging reactive oxygen species (ROS) and suppressing inflammation to ameliorate secondary injury using biomaterials has turned into a promising strategy for SCI recuperation. Herein, epigallocatechin-3-gallate selenium nanoparticles (EGCG-Se NP) that scavenge ROS and attenuate inflammation were used for neuroprotection in SCI.Methods: EGCG-Se NP were arranged using a simple redox framework. The size, morphology, and chemical structure of the EGCG-Se NP were characterized. The protective effect of EGCG-Se NP for neuroprotection was examined in cell culture and in an SCI rat model.Results: EGCG-Se NP could promptly scavenge excess ROS and safeguard PC12 cells against H2O2-induced oxidative harm in vitro. After intravenous delivery in SCI rats, EGCG-Se NP significantly improved locomotor capacity and diminished the injury region by safeguarding neurons and myelin sheaths. Component studies showed that the main restorative impact of EGCG-Se NP was due to their ROS-scavenging and anti-inflammatory properties.Conclusion: This study showed the superior neuroprotective effect of EGCG-Se NP through ROS sequestration and anti-inflammatory capabilities. EGCG-Se NP could be a promising and effective treatment for SCI.